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Biomonitoring studies involve the measure-
ment of chemical concentrations in blood, 
urine, or tissues of a large number of indi-
viduals to assess the exposure of a population 
to environmental contaminants. Such studies 
may provide information about the chemi-
cals a population is exposed to, changes in 
exposure over time, and factors that influence 
exposure. Numerous cross-sectional biomoni-
toring studies (Becker et al. 2003; Jursa et al. 
2006; Uemura et al. 2008) have reported 
human body burdens of polychlorinated 
biphenyls (PCBs) that increase monotoni-
cally with age (Figure 1A–C), leading some 
authors to conclude that bioaccumulation 
increases with age because of longer exposure 
(Fernandez et al. 2008; Hardell et al. 2010; 
James et al. 2002; Naert et al. 2006) or age-
dependent changes in metabolism (Ahlborg 
et al. 1995; Fangstrom et al. 2005). An alter-
native hypothesis is that older individuals 
lived during periods of greater PCB exposure 
(Ahlborg et al. 1995; Patterson et al. 2008; 
Porta et al. 2008). A recent review by Porta 
et al. (2008) highlighted that the interplay 
between age effects and birth cohort effects 
has yet to be quantitatively evaluated.
Not all cross-sectional body burden-  versus-
age trends (CBATs) for PCBs consistently 
increase with age however (Figure 1D–H) 
(Duarte-Davidson et al. 1994; Finklea 
et al. 1972; Kiviranta et al. 2005; Kreiss 
et al. 1981; Naert et al. 2006; Thomas et al. 
2006). Furthermore, in contrast with data for 
PCBs, cross-sectional data from Australia for   
2002–2007 suggest a decreasing trend in serum 
concentrations of polybrominated diphenyl 
ethers (PBDEs) with age (Figure 1I) (Mueller 
and Toms 2010). Covaci et al. (2008) pro-
posed that opposing age trends for PCBs and 
PBDEs may suggest that PCBs have reached 
steady-state levels in human tissues. They also 
suggest that different exposure routes and 
metabolic rates could explain this difference. 
Others have proposed that the body burdens of 
infants are greater than those of adults because 
under steady-state conditions, exposure from 
breast milk is greater than that from adult food 
sources (Johnson-Restrepo and Kannan 2009).
The mechanistic bioaccumulation model 
CoZMoMAN (Breivik et al. 2010) suggests 
that in individuals with constant exposure, 
lipid-normalized body burdens of persistent 
PCB congeners may actually decrease after 
age 50 (Quinn et al. 2011). We propose that 
the increase in PCB body burden with age 
observed in cross-sectional population studies 
is a result of the timing of sample collection 
relative to peak PCB emissions, which deter-
mines the peak in exposure. In the present 
study, we used the CoZMoMAN model to 
investigate factors that influence the shape of 
CBATs and relate these findings to observed 
CBATs reported in the literature. Ritter et al. 
(2011) recently applied a pharmacokinetic 
model to cross-sectional biomonitoring data 
to estimate intrinsic elimination half-lives of 
PCBs in humans. They also derived CBATs 
from their model, which relies on contami-
nant measurements in food to empirically esti-
mate time trends in exposure. In the present 
study, we go beyond this approach by apply-
ing a mechanistic multimedia fate model to 
quantify time-variant exposure. Furthermore, 
our analyses include both pre- and post  ban 
populations rather than focusing only on the 
post  ban situation.
Methods
The previously evaluated mechanistic time-
variant multimedia model CoZMoMAN 
(Breivik et al. 2010) was used to esti-
mate CBATs for several chemicals varying 
in partitioning and degradation properties. 
CoZMoMAN calculates the transfer of time-
variant emissions of an organic chemi-
cal through atmospheric, aqueous, and 
terrestrial compartments and its subsequent 
bio  accumulation in the food web and transfer 
to humans through the uptake of contami-
nated food, air, and water. Each environ-
mental phase is modeled as one compartment, 
and the human is modeled as two compart-
ments—the digestive tract and the main body 
(Czub and McLachlan 2004). Internal kinetic 
distributions are not considered. The model 
requires information on the contaminant’s 
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octanol–water and octanol–air partition coeffi-
cients (log KOW and log KOA, respectively), its 
environmental and metabolic half-lives, and 
the historical time trend of its emissions. A 
detailed discussion of the model can be found 
in Breivik et al. (2010) and references therein.
Cross-sectional data generated through 
biomonitoring studies are based on groups of 
different individuals sampled at the same time, 
whereas the longitudinal estimates derived by 
CoZMoMAN are for single individuals over 
their entire lifetimes. For the present analysis, 
cross-sectional trends were determined from 
model-derived longi  tudinal estimates of lipid-
normalized concentrations for individual 
women born at 5-year intervals starting several 
decades before emissions of the chemical to 
the environment began and ending several 
decades after emissions ceased. Each simulated 
woman was an only child born to a 30-year-
old mother and breast-fed for 6 months, each 
had one child of her own at age 30 that she 
breast-fed for 6 months, and each died at age 
80. The process of deriving CBATs from the 
longitudinal body burden age trends (LBATs) 
simulated for individual women is illustrated 
in Figure 2 for PCB congener 153 (PCB-153) 
(log KOW = 7; log KOA = 9.5) assuming the 
historical atmospheric emissions profile 
(Figure 2A) (Breivik et al. 2010), dietary 
intakes for southern Sweden (Figure 2C) 
(Quinn et al. 2011), changes in body weight 
and lipid weight with age (Figure 2D) (Czub 
and McLachlan 2004), and a constant age-
independent metabolic rate. Unless otherwise 
noted, all PCB-153 emissions are assumed to 
have been released into the atmosphere.
In this example, 17 different LBATs (for 
17 individual women 0, 5, 10 . . . 80 years of 
age) were used to estimate each CBAT, with 
each LBAT contributing one data point to a 
given CBAT. For example, to derive a CBAT 
for PCB-153 measured in a cross-sectional 
population in the year 2000, the body bur-
den for a 30-year-old is taken from the LBAT 
estimated for a woman born in 1970, and 
the body burden of an 80-year-old is taken 
from the LBAT estimated for a woman born 
in 1920 (Figure 2E).
In all simulations, we estimated dietary 
intakes assuming a typical Swedish diet, 
which corresponds to daily consumption of 
50 g dairy lipid, 12 g beef lipid, and 75 g wet 
weight fish for 25-year-old women (Czub 
and McLachlan 2004). We assumed that the 
dietary proportions of dairy, beef, and fish 
were constant over time but that daily con-
sumption varied with age (Figure 2C) (Moser 
and McLachlan 2002).
Because the focus of the analyses was on 
the shape of the CBATs and not on absolute 
human body burdens, estimated body burdens 
for individual women (at different ages) were 
normalized to the average value of the popula-
tion cross section at that point in time. For 
each scenario, CN(t), the normalized concen-
tration for a woman of age t, was calculated as 
Ct/Cavg, where Ct is the estimated concentra-
tion for a woman of age t and Cavg is the aver-
age estimated concentration of the population 
cross section for the given scenario. In other 
words, the CBATs reflect the body burden of 
a woman at a given age relative to the average 
of the entire population.
Sensitivity analyses. To identify and better 
understand the factors that may influence the 
shape of CBATs, we performed additional 
hypothetical simulations in a series of sensitiv-
ity analyses. The influence of human meta-
bolic half-lives on CBAT shape was evaluated 
for a hypothetical chemical of log KOW 7 and 
log KOA 9.5 (corresponding to the partition-
ing properties of PCB-153) and five different 
half-lives of 1, 3, 5, 15, and 50 years.
Figure 1. Literature-reported CBATs for PCBs for Germany (A; Becker et al. 2003), Slovakia (B; Jursa et al. 2006), Japan (C; Uemura et al. 2008), the U.S. states 
of South Carolina (D; Finklea et al. 1972) and Alabama (E; Kreiss et al. 1981), southern Finland (F; Kiviranta et al. 2005), Belgium (G; Naert et al. 2006), and the 
United Kingdom (H; Duarte-Davidson et al. 1994; Thomas et al. 2006) and for measurements for both PCB and PBDE for Australia (I; Mueller and Toms 2010). 
Abbreviations: TEQ, toxic equivalent concentration; WHO, World Health Organization.
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To explore the influence of the length of 
the emission period on CBAT shapes, we per-
formed additional simulations for a chemical 
with the partitioning properties of PCB-153 
(log KOW = 7; log = KOA 9.5) according to 
three different metabolic half-lives (1, 15, and 
50 years) and three hypothetical emission sce-
narios represented by bell-shaped functions 
that increased and decreased over 30, 50, and 
100 years, respectively (Figure 3). The rate of 
decline represents emission half-lives of 1.8, 
8.5, and 10 years, respectively.
To explore the influence of partitioning 
properties, we estimated CBATs for four hypo-
thetical partitioning property combinations 
Figure 2. Schematic overview of how the CoZMoMAN model estimates CBATs for PCB-153: historical atmospheric emission estimates (A; adapted from Breivik 
et al. 2010) are used to derive time trends in the concentrations in air and water (B) using a physical environmental fate model. These concentrations in exposure-
relevant environmental media, as well as assumptions concerning dietary composition (C) and growth curves for these women (D; adapted from Czub and 
McLachlan 2004), are used to calculate LBATs for women born every 5 years (E) using a human food chain bioaccumulation model. Finally, CBATs for 1968, 2000, 
and 2030 are obtained by “sampling” the women whose LBATs had been estimated. ww, wet weight.
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representing the range of potentially bio-
accumulative chemicals in the human food 
chain (Kelly et al. 2007): log KOW  4 
and log KOA 7.4, log KOW 5.6 and log 
KOA 7.2, log KOW 7 and log KOA 9.7, and 
log KOW 8.7 and log KOA 15.3, corre-
sponding to the partitioning properties of 
α-hexachlorocyclohexane, hexachlorobenzene, 
p,p´-dichlorodiphenyldichloroethylene, and 
decabrominated diphenyl ether, respectively. 
For these analyses, we assumed a human 
metabolic half-life of 15 years and the 50-year 
  emission scenario.
We evaluated the influence of model 
assumptions regarding age trends in lipid con-
tent and liver metabolic capacity assuming 
the partitioning properties of PCB-153 and 
the 50-year emission scenario. Specifically, we 
assumed a slower increase in body fat between 
ages 20 and 80 such that at age 80 the female 
body lipid content was only 20 kg (27% of 
body weight) rather than 30 kg (40% of body 
weight; Figure 2D). Because the body burdens 
are lipid normalized, a lower body fat content 
would translate into greater body burdens. To 
determine if age-dependent metabolic degra-
dation capacity as a function of liver volume 
could influence CBAT shape, we modified the 
metabolic degradation rate to be dependent on 
liver volume according to Alcock et al. (2000), 
assuming age-dependent changes in liver vol-
ume according to van der Molen et al. (1996).
Results and Discussion
PCB-153 CBATs calculated every 10 years 
from 1950 to 2050 for women in Sweden, 
derived as described above, are shown in 
Figure 4. The shape of CBATs for PCB-153 
depends strongly on the year of sampling rela-
tive to the emissions profile, which peaked in 
1974 in this scenario. These results highlight 
the gradual shifts among age groups over time 
and the influence of the time of sampling rela-
tive to the emission time trend, which is cru-
cial to understanding the relation between age 
and PCB body burden based on cross-sectional 
data collected at different points in time.
A pattern common to all of the CBATs is 
a drop in estimated PCB-153 levels in women 
at age 30, when all of the women included in 
the simulations give birth to a child (Quinn 
et al. 2011). For an entirely nulliparous female 
population, the CBAT minimum would 
actually occur at age 15 [see Supplemental 
Material, Figure 1 (http://dx.doi.org/10.1289/
ehp.1104236)]. In a realistic population, the 
effects of reproduction on PCB-153 concen-
trations in a cross-sectional sample would be 
obscured because of variation in the age of 
childbirth, the number of children, and breast-
feeding practices.
CBATs during times of increasing emis-
sions. When emissions are still increasing 
(i.e., 1950–1970), CoZMoMAN predicts 
the highest body burdens in females around 
5 years of age (Figure 4). This reflects the com-
bined effects of increasing prenatal exposure 
with each generation and the relatively low 
body lipid content at age 5 (Figure 2D). In 
other words, 5-year-olds in a biomonitoring 
study conducted when emissions are increas-
ing will have a greater body burden than will 
15-year-olds because they were born into a 
more contaminated environment and because 
they have yet to go through a substantial 
growth dilution phase during their teens. The 
model predicts that PCB levels will decrease 
in women > 40 years of age sampled during 
times of increasing emissions, not because lev-
els decrease in individuals with age but because 
women who were > 40 years of age when these 
cross-sectional samples were assembled were 
not exposed until later in life.
CBATs during times of decreasing emissions. 
The age at which the maximum body burden 
occurs in a CBAT during times of decreasing 
emissions depends upon the amount of time 
elapsed since the emissions peaked. That is, the 
age at which the maximum body burden occurs 
in adults will increase as the time between the 
peak of emissions and cross-sectional sampling 
increases (Figure 4). In CBATs representing the 
period after emissions have completely ended, 
there is a rapid increase in body burden with 
age because the contaminated population is 
older and exposure is relatively low in younger 
members of the population. The Michigan fish-
eater cohort, which is one of the few longitudi-
nal data sets reported in the literature (Tee et al. 
2003), illustrates this effect. In 1980, serum 
PCB concentrations were greatest for individu-
als 50–59 years of age. Ten years later, serum 
PCB concentrations were highest for the same 
group of people, who were now 60–69 years 
of age. This supports our interpretation that 
the trend of increasing body burden with age 
observed in cross-sectional PCB biomonitoring 
studies is due to an emissions-related cohort 
effect rather than an age-dependent decline in 
metabolism (Ahlborg et al. 1995; Fangstrom 
et al. 2005) or bio  accumulation (Fernandez 
et al. 2008; Hardell et al. 2010; James et al. 
2002; Naert et al. 2006).
Comparison of measured and pre-
dicted CBATs for PCBs. Our model results 
suggest that the CBAT reported by Finklea 
et al. (1972), based on a population from 
the U.S. state of South Carolina sampled in 
1968—which is the only CBAT that did not 
show a clear relationship between age and 
PCB body burden (Figure 1D)—is consis-
tent with expectations given that the popula-
tion was sampled at a time close to the peak 
in PCB emissions. The CBAT from Finklea 
et al. (1972) is consistent with the CBAT esti-
mated by CoZMoMAN for 1980. In contrast, 
almost all other CBATs shown in Figure 1 
show increasing body burdens with age, which 
is consistent with the CoZMoMAN-predicted 
CBATs for the time periods when these sam-
ples were collected, which in most cases were 
> 30 years after the PCB emission peak in the 
early 1970s. Biomonitoring studies focusing on 
adults would not resolve the peak in body bur-
den that CoZMoMAN predicts for children. 
Figure 3. Shape of three theoretical emission 
  scenarios lasting 30, 50, and 100 years.
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However, a survey of PCBs in children from 
the Faroe Islands in 1986–1987 revealed that 
the serum concentrations of PCBs in 7-year-
olds were two to three times greater than those 
in 14-year-olds and two to eight times greater 
than those measured in newborn cord blood 
(Barr et al. 2006). Results of the GerES IV 
(German Environmental Survey 2003/06) for 
children indicated that 7- to 8-year-olds had 
20% greater PCB serum concentrations than 
did 12- to 14-year-olds (Becker et al. 2008). 
These studies support the influence of growth 
dilution on the relation between age and PCB 
body burden.
Sensitivity analyses. Of the parameters eval-
uated using sensitivity analyses, the metabolic 
half-life in humans had the greatest influence 
on CBAT shape (Figure 5). For sampling times 
before the peak in emissions (tmax), the human 
metabolic half-life has little influence on CBAT 
shape. After emission peak (years > tmax), the 
CBAT shape is similar for all sampling times 
when the half-life is ≥ 15 years, but for chemi-
cals with half-lives of 3–5 years, the transition 
between CBAT shapes over time is delayed by 
10–20 years relative to substances with a half-
life of 15 years. Over the long term, the same 
CBAT shapes are observed for chemicals with a 
half-life of 3 years as for chemicals with a half-
life of 15 years. However, for a chemical with 
a half-life of 1 year, the CBAT shape is always 
the same regardless of sampling time, and only 
the relative intensity of the maximum changes 
over time [see Supplemental Material, Figure 2 
(http://dx.doi.org/10.1289/ehp.1104236)].
Recent work by Ritter et al. (2011) 
showed that CBATs could be used to derive 
information on the intrinsic human elimina-
tion half-life. Observations from the present 
analysis suggest that the method described 
by Ritter et al. (2011) to derive such half-
lives from CBATs will work better late in the 
emissions cycle (t > tmax + 20 years) and when 
the half-life is between 1 and 10 years. The 
CBAT shapes for chemical half-lives outside 
of this regime will be very similar (Figure 5).
For all emission scenarios, the CBATs 
remained unchanged with time for a human 
metabolic half-life of 1 year [Supplemental 
Material, Figure 3 (http://dx.doi.org/10.1289/
ehp.1104236)]. For a 100-year emission sce-
nario, the CBAT shape was also unchanged 
with time for a 15-year human metabolic half-
life but showed time-dependent behavior with 
a 50-year human metabolic half-life. When 
the metabolic half-life was 15 and 50 years, 
the 30- and 50-year emission periods yielded 
similar CBATs at each time point. From these 
calculations, we hypothesize that for chemicals 
with a human metabolic half-life similar to or 
shorter than the emissions half-life, the CBAT 
shape will be constant over all time points. 
For chemicals with human metabolic half-life 
greater than the emissions half-life, temporal 
transitions in CBAT shapes will be observed.
Within the investigated range of partition-
ing properties, virtually no impact on the shape 
of the CBATs was observed [Supplemental 
Material, Figure 4 (http://dx.doi.org/10.1289/
ehp.1104236)]. This is because the LBAT 
curves for individuals do not change signifi-
cantly except for the magnitude of bioaccu-
mulation. This finding is supported by the 
work of Arnot et al. (2010), who observed 
similar age patterns in human dietary intake 
of organic contaminants with a wide range 
of partitioning properties. Model assump-
tions regarding lipid content and liver meta-
bolic capacity also had little impact on CBAT 
shapes (Supplemental Material, Figure 5).
CBATs of PCB mixtures. PCB concentra-
tions in human tissues are often reported as 
the sum of several detected congeners (e.g., 
dioxin-like PCBs). Each congener will have a 
unique metabolic half-life, partitioning prop-
erties, and possibly also emissions profiles. 
To determine how the combination of these 
traits for individual congeners influences the 
CBATs of PCB mixtures, we calculated a 
CBAT for the combination of PCB conge-
ners 52, 101, 118, 138, 153, and 180 [see 
Supplemental Material, Table 1, Figure 6 
(http://dx.doi.org/10.1289/ehp.1104236)] 
for realistic Swedish emissions scenarios 
(Breivik et al. 2010). From this calculation, it 
is apparent that the CBAT shapes for the PCB 
mixture resemble closely the CBATs of the 
congeners with the longest metabolic half-life 
(Supplemental Material, Figure 6B), because 
those congeners contribute the most to the 
PCB body burden (Supplemental Material, 
Figure 6A).
How do the CBATs of PCBs and PBDEs 
compare? We propose that the CBAT shapes 
in any given sampling year should look signifi-
cantly different for PCBs and PBDEs based 
solely upon differences in emissions trends 
over time and human metabolic half-lives. 
Although the production of PCBs has been 
banned globally for several decades (Breivik 
et al. 2007), the production of PBDEs is still 
increasing in some areas (Ward et al. 2008). 
Thus, current cross-sectional biomonitor-
ing efforts for PBDEs will yield CBATs with 
different shapes than CBATs for PCBs. In 
addition, the apparent elimination half-life 
of PBDEs is estimated to be several months 
(Thuresson et al. 2006), compared with 
elimination half-lives in excess of a decade 
for highly bioaccumulative PCBs (Brown 
et al. 1989). CBATs estimated for chemicals 
with human metabolic half-lives of 1 year 
and 15 years are therefore relevant to a com-
parison of CBATs for PBDEs versus PCBs 
(Figure 5). At tmax – 20 years, CBATs for both 
compounds suggest that children at 5 years of 
age have greater body burdens than do either 
infants or adult women, consistent with previ-
ously reported PBDE biomonitoring studies 
(Sjodin et al. 2008; Toms et al. 2008, 2009). 
At tmax + 20 years, the CBAT for a chemical 
with a human metabolic half-life of 1 year still 
Figure 5. Comparison of CoZMoMAN-generated CBATs for chemicals with log KOW 7 and log KOA 9.5 and a human metabolic half-life of 1, 3, 5, 15, and 50 years, 
assuming a bell-shaped emission scenario lasting 50 years. Note that the y-axis scale is smaller for the top row than for the bottom row y-axis.
3
2
1
0
6
4
2
0
N
o
r
m
a
l
i
z
e
d
 
b
o
d
y
 
b
u
r
d
e
n
02 04 0
tmax–20
tmax+30
tmax–10
tmax+40
tmax+10
tmax+60
tmax+20
tmax+70
tmax
tmax+50
60 02 04 06 0020 40
Age (years)
60 02 04 06 0020 40 60 80
02 04 06 0020 40 60 02 04 06 0020 40 60 02 04 06 08 0
1 year 3 years 5 years 15 years 50 years Metabolic half-lifeInterpreting cross-sectional trends
Environmental Health Perspectives  •  v o l u m e  120 | n u m b e r 4 | April 2012  559
presents the same age trends, but the CBAT 
for a chemical with a 15-year metabolic half-
life shows increasing cross-sectional body 
burdens from 10 to 50 years of age. Because 
PBDEs are better represented by a metabolic 
half-life of 1 year than 15 years (Thuresson 
et al. 2006), we propose that CBATs for 
PBDEs will exhibit the same CBAT shape 
regardless of the sampling year. In addition, 
the shape of CBATs for PCBs and PBDEs 
would be similar only if they were both based 
on population cross sections sampled during 
periods of increasing emissions.
Conclusions
Our analysis of CBAT shapes and the influ-
ence of various model parameters suggests that 
the most important influences on the shape of 
cross-sectional time trends are the temporal 
relationship between the emissions scenario 
time trend and the biomonitoring sample col-
lection period, and the human metabolic half-
life. Although the extent of bioaccumulation 
of a chemical is also influenced by its parti-
tioning properties, the length of the emissions 
period, and lipid content and liver clearance 
rates in the population, the age trend in cross-
sectional studies is largely unaffected by these 
factors. Our results suggest that the observed 
increase in PCB body burdens for elderly indi-
viduals is consistent with an emissions-related 
cohort effect, and that differences in CBAT 
shapes for PCBs and PBDEs are consistent 
with differences in human metabolic rates and 
emission scenarios.
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